Is SCHD a Good ETF to Buy?
With around $65.7 billion in net assets, Schwab’s US Dividend…
Buy
67
MBAI.CX Quote, Financials, Valuation and Earnings
Last price:
$0.07
Seasonality move
:
42.5%
Day range:
$0.07 - $0.08
52-week range:
$0.02 - $0.28
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.35x
Volume:
672K
Avg. volume:
543.2K
1-year change:
-75.93%
Market cap:
$7.2M
Revenue:
--
EPS (TTM):
-$0.01
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
MBAI.CX
MedBright AI Investments
|
-- | -- | -- | -- | -- |
|
GPK.CX
Grand Peak Capital
|
-- | -- | -- | -- | -- |
|
IDK.CX
ThreeD Capital
|
-- | -- | -- | -- | -- |
|
PXI.CX
Planet Ventures
|
-- | -- | -- | -- | -- |
|
QCA.CX
Quinsam Capital
|
-- | -- | -- | -- | -- |
|
TEAM.CX
Canadian Nexus Team Ventures
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
MBAI.CX
MedBright AI Investments
|
$0.07 | -- | $7.2M | -- | $0.00 | 0% | -- |
|
GPK.CX
Grand Peak Capital
|
$0.1000 | -- | $15.9M | -- | $0.00 | 0% | 27.04x |
|
IDK.CX
ThreeD Capital
|
$0.20 | -- | $11.3M | 3.44x | $0.00 | 0% | 1.44x |
|
PXI.CX
Planet Ventures
|
$0.04 | -- | $7.2M | 1.41x | $0.00 | 0% | 7.61x |
|
QCA.CX
Quinsam Capital
|
$0.05 | -- | $4.2M | -- | $0.00 | 0% | -- |
|
TEAM.CX
Canadian Nexus Team Ventures
|
$0.15 | -- | $1.3M | -- | $0.00 | 0% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
MBAI.CX
MedBright AI Investments
|
-- | -0.102 | -- | -- |
|
GPK.CX
Grand Peak Capital
|
-- | 38.552 | -- | 13.89x |
|
IDK.CX
ThreeD Capital
|
0.93% | 1.281 | 3.1% | 1.45x |
|
PXI.CX
Planet Ventures
|
-- | 2.649 | -- | 9.06x |
|
QCA.CX
Quinsam Capital
|
-- | -0.559 | -- | 27.94x |
|
TEAM.CX
Canadian Nexus Team Ventures
|
-- | 1.378 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
MBAI.CX
MedBright AI Investments
|
-- | -$246K | -- | -- | -- | -$186.5K |
|
GPK.CX
Grand Peak Capital
|
$222.6K | $180.3K | -39.07% | -39.07% | 80.99% | -$96.5K |
|
IDK.CX
ThreeD Capital
|
-- | -- | -8.47% | -8.56% | -4693.13% | -$737.7K |
|
PXI.CX
Planet Ventures
|
$1.3M | -$903.9K | 45.21% | 45.21% | 141.96% | -$1.2M |
|
QCA.CX
Quinsam Capital
|
-$576.3K | $1.2M | -2.62% | -2.62% | -234.02% | -$517.9K |
|
TEAM.CX
Canadian Nexus Team Ventures
|
-$61.8K | -$148.4K | -- | -- | -- | -$68.2K |
MedBright AI Investments vs. Competitors
-
Which has Higher Returns MBAI.CX or GPK.CX?
Grand Peak Capital has a net margin of -- compared to MedBright AI Investments's net margin of 81.22%. MedBright AI Investments's return on equity of -- beat Grand Peak Capital's return on equity of -39.07%.
Company Gross Margin Earnings Per Share Invested Capital MBAI.CXMedBright AI Investments-- -$0.00 -- GPK.CXGrand Peak Capital68.21% $0.00 $3.2M -
What do Analysts Say About MBAI.CX or GPK.CX?
MedBright AI Investments has a consensus price target of --, signalling downside risk potential of --. On the other hand Grand Peak Capital has an analysts' consensus of -- which suggests that it could fall by --. Given that MedBright AI Investments has higher upside potential than Grand Peak Capital, analysts believe MedBright AI Investments is more attractive than Grand Peak Capital.
Company Buy Ratings Hold Ratings Sell Ratings MBAI.CXMedBright AI Investments0 0 0 GPK.CXGrand Peak Capital0 0 0 -
Is MBAI.CX or GPK.CX More Risky?
MedBright AI Investments has a beta of -0.066, which suggesting that the stock is 106.645% less volatile than S&P 500. In comparison Grand Peak Capital has a beta of 1.201, suggesting its more volatile than the S&P 500 by 20.13%.
-
Which is a Better Dividend Stock MBAI.CX or GPK.CX?
MedBright AI Investments has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Grand Peak Capital offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. MedBright AI Investments pays -- of its earnings as a dividend. Grand Peak Capital pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MBAI.CX or GPK.CX?
MedBright AI Investments quarterly revenues are --, which are smaller than Grand Peak Capital quarterly revenues of $222.6K. MedBright AI Investments's net income of -$303.3K is lower than Grand Peak Capital's net income of $180.8K. Notably, MedBright AI Investments's price-to-earnings ratio is -- while Grand Peak Capital's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MedBright AI Investments is -- versus 27.04x for Grand Peak Capital. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MBAI.CXMedBright AI Investments-- -- -- -$303.3K GPK.CXGrand Peak Capital27.04x -- $222.6K $180.8K
-
Which has Higher Returns MBAI.CX or IDK.CX?
ThreeD Capital has a net margin of -- compared to MedBright AI Investments's net margin of -5609.87%. MedBright AI Investments's return on equity of -- beat ThreeD Capital's return on equity of -8.56%.
Company Gross Margin Earnings Per Share Invested Capital MBAI.CXMedBright AI Investments-- -$0.00 -- IDK.CXThreeD Capital-- -$0.02 $45.5M -
What do Analysts Say About MBAI.CX or IDK.CX?
MedBright AI Investments has a consensus price target of --, signalling downside risk potential of --. On the other hand ThreeD Capital has an analysts' consensus of -- which suggests that it could fall by --. Given that MedBright AI Investments has higher upside potential than ThreeD Capital, analysts believe MedBright AI Investments is more attractive than ThreeD Capital.
Company Buy Ratings Hold Ratings Sell Ratings MBAI.CXMedBright AI Investments0 0 0 IDK.CXThreeD Capital0 0 0 -
Is MBAI.CX or IDK.CX More Risky?
MedBright AI Investments has a beta of -0.066, which suggesting that the stock is 106.645% less volatile than S&P 500. In comparison ThreeD Capital has a beta of 1.492, suggesting its more volatile than the S&P 500 by 49.18%.
-
Which is a Better Dividend Stock MBAI.CX or IDK.CX?
MedBright AI Investments has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. ThreeD Capital offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. MedBright AI Investments pays -- of its earnings as a dividend. ThreeD Capital pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MBAI.CX or IDK.CX?
MedBright AI Investments quarterly revenues are --, which are smaller than ThreeD Capital quarterly revenues of $19.6K. MedBright AI Investments's net income of -$303.3K is higher than ThreeD Capital's net income of -$1.1M. Notably, MedBright AI Investments's price-to-earnings ratio is -- while ThreeD Capital's PE ratio is 3.44x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MedBright AI Investments is -- versus 1.44x for ThreeD Capital. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MBAI.CXMedBright AI Investments-- -- -- -$303.3K IDK.CXThreeD Capital1.44x 3.44x $19.6K -$1.1M
-
Which has Higher Returns MBAI.CX or PXI.CX?
Planet Ventures has a net margin of -- compared to MedBright AI Investments's net margin of -417.41%. MedBright AI Investments's return on equity of -- beat Planet Ventures's return on equity of 45.21%.
Company Gross Margin Earnings Per Share Invested Capital MBAI.CXMedBright AI Investments-- -$0.00 -- PXI.CXPlanet Ventures96.1% $0.01 $11.3M -
What do Analysts Say About MBAI.CX or PXI.CX?
MedBright AI Investments has a consensus price target of --, signalling downside risk potential of --. On the other hand Planet Ventures has an analysts' consensus of -- which suggests that it could fall by --. Given that MedBright AI Investments has higher upside potential than Planet Ventures, analysts believe MedBright AI Investments is more attractive than Planet Ventures.
Company Buy Ratings Hold Ratings Sell Ratings MBAI.CXMedBright AI Investments0 0 0 PXI.CXPlanet Ventures0 0 0 -
Is MBAI.CX or PXI.CX More Risky?
MedBright AI Investments has a beta of -0.066, which suggesting that the stock is 106.645% less volatile than S&P 500. In comparison Planet Ventures has a beta of 3.045, suggesting its more volatile than the S&P 500 by 204.519%.
-
Which is a Better Dividend Stock MBAI.CX or PXI.CX?
MedBright AI Investments has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Planet Ventures offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. MedBright AI Investments pays -- of its earnings as a dividend. Planet Ventures pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MBAI.CX or PXI.CX?
MedBright AI Investments quarterly revenues are --, which are smaller than Planet Ventures quarterly revenues of $1.3M. MedBright AI Investments's net income of -$303.3K is lower than Planet Ventures's net income of $1.9M. Notably, MedBright AI Investments's price-to-earnings ratio is -- while Planet Ventures's PE ratio is 1.41x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MedBright AI Investments is -- versus 7.61x for Planet Ventures. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MBAI.CXMedBright AI Investments-- -- -- -$303.3K PXI.CXPlanet Ventures7.61x 1.41x $1.3M $1.9M
-
Which has Higher Returns MBAI.CX or QCA.CX?
Quinsam Capital has a net margin of -- compared to MedBright AI Investments's net margin of -234.02%. MedBright AI Investments's return on equity of -- beat Quinsam Capital's return on equity of -2.62%.
Company Gross Margin Earnings Per Share Invested Capital MBAI.CXMedBright AI Investments-- -$0.00 -- QCA.CXQuinsam Capital85.34% $0.01 $13.4M -
What do Analysts Say About MBAI.CX or QCA.CX?
MedBright AI Investments has a consensus price target of --, signalling downside risk potential of --. On the other hand Quinsam Capital has an analysts' consensus of -- which suggests that it could fall by --. Given that MedBright AI Investments has higher upside potential than Quinsam Capital, analysts believe MedBright AI Investments is more attractive than Quinsam Capital.
Company Buy Ratings Hold Ratings Sell Ratings MBAI.CXMedBright AI Investments0 0 0 QCA.CXQuinsam Capital0 0 0 -
Is MBAI.CX or QCA.CX More Risky?
MedBright AI Investments has a beta of -0.066, which suggesting that the stock is 106.645% less volatile than S&P 500. In comparison Quinsam Capital has a beta of 1.172, suggesting its more volatile than the S&P 500 by 17.197%.
-
Which is a Better Dividend Stock MBAI.CX or QCA.CX?
MedBright AI Investments has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Quinsam Capital offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. MedBright AI Investments pays -- of its earnings as a dividend. Quinsam Capital pays out -6.06% of its earnings as a dividend.
-
Which has Better Financial Ratios MBAI.CX or QCA.CX?
MedBright AI Investments quarterly revenues are --, which are smaller than Quinsam Capital quarterly revenues of -$517.6K. MedBright AI Investments's net income of -$303.3K is lower than Quinsam Capital's net income of $1.2M. Notably, MedBright AI Investments's price-to-earnings ratio is -- while Quinsam Capital's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MedBright AI Investments is -- versus -- for Quinsam Capital. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MBAI.CXMedBright AI Investments-- -- -- -$303.3K QCA.CXQuinsam Capital-- -- -$517.6K $1.2M
-
Which has Higher Returns MBAI.CX or TEAM.CX?
Canadian Nexus Team Ventures has a net margin of -- compared to MedBright AI Investments's net margin of --. MedBright AI Investments's return on equity of -- beat Canadian Nexus Team Ventures's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital MBAI.CXMedBright AI Investments-- -$0.00 -- TEAM.CXCanadian Nexus Team Ventures-- -$0.02 -- -
What do Analysts Say About MBAI.CX or TEAM.CX?
MedBright AI Investments has a consensus price target of --, signalling downside risk potential of --. On the other hand Canadian Nexus Team Ventures has an analysts' consensus of -- which suggests that it could fall by --. Given that MedBright AI Investments has higher upside potential than Canadian Nexus Team Ventures, analysts believe MedBright AI Investments is more attractive than Canadian Nexus Team Ventures.
Company Buy Ratings Hold Ratings Sell Ratings MBAI.CXMedBright AI Investments0 0 0 TEAM.CXCanadian Nexus Team Ventures0 0 0 -
Is MBAI.CX or TEAM.CX More Risky?
MedBright AI Investments has a beta of -0.066, which suggesting that the stock is 106.645% less volatile than S&P 500. In comparison Canadian Nexus Team Ventures has a beta of 1.079, suggesting its more volatile than the S&P 500 by 7.942%.
-
Which is a Better Dividend Stock MBAI.CX or TEAM.CX?
MedBright AI Investments has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Canadian Nexus Team Ventures offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. MedBright AI Investments pays -- of its earnings as a dividend. Canadian Nexus Team Ventures pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MBAI.CX or TEAM.CX?
MedBright AI Investments quarterly revenues are --, which are smaller than Canadian Nexus Team Ventures quarterly revenues of --. MedBright AI Investments's net income of -$303.3K is lower than Canadian Nexus Team Ventures's net income of -$148.6K. Notably, MedBright AI Investments's price-to-earnings ratio is -- while Canadian Nexus Team Ventures's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MedBright AI Investments is -- versus -- for Canadian Nexus Team Ventures. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MBAI.CXMedBright AI Investments-- -- -- -$303.3K TEAM.CXCanadian Nexus Team Ventures-- -- -- -$148.6K
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is NAIL a Good ETF to Buy?
If you’re thinking about buying the NAIL ETF, this article…
3 High Dividend Dow Jones Stocks
Thanks to surging stock prices over the past two years,…
Stock Ideas
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Sell
43
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 36x
Alerts
Buy
57
NARI alert for Jan 8
Inari Medical [NARI] is up 22.25% over the past day.
Buy
69
UNF alert for Jan 8
UniFirst [UNF] is up 20.59% over the past day.
Sell
31
APOG alert for Jan 8
Apogee Enterprises [APOG] is down 19.13% over the past day.
